FabriceAndre
@FAndreMD
Head of Research Division of @GustaveRoussy , @myesmo President Elect
ID:4061204056
28-10-2015 14:23:49
3,0K Tweets
13,7K Followers
520 Following
.ESMO - Eur. Oncology recommendations for the use of NGS is published in Annals of Oncology . >200 references ! Breast cancer is one of the new indications. A special mention is done for tumor-agnostic indications. A big work from @fermosele and the precision medicine group of ESMO
Presented by Rebecca Dent at #ESMOBreast24 w/ simultaneous publication in Annals of Oncology 1st results of Impassion132 showing no benefit of adding #atezoliyumab to 1st line CT in pts w/ advanced #TNBC relapsing <12months.
#AnnOnc #BreastCancer tinyurl.com/5n99udja
In this review The Lancet , S Delaloge Gustave Roussy & coll discuss how risk assessment could improve the quality of care in pts with in situ breast carcinoma. This risk-based approach is the foundation of modern cancer prevention centers thelancet.com/journals/lance…
📰 Kick-off de l’IHU Prism Center :
Ce jeudi 2 mai s’est tenu à l’espace Maurice Tubiana de Gustave Roussy le kick-off de l’IHU #Prism , cofondé par CentraleSupélec, Gustave Roussy, l’Inserm, Unicancer et l’ Université Paris-Saclay.
Lire l'actualité ➡ gustaveroussy.fr/fr/kick-de-lih…
During the visit, our chief clinician, Charles Swanton, highlighted some of the innovative research that Cancer Research UK is supporting at the hospital, including our single biggest investment in lung cancer research, TRACERx.
It’s been lovely to hear how much the visit meant to patients
The kick-off Meeting of the Prism Center IHU-A will be on Thursday May 2nd. It’s an opportunity to organise a nice seminar around Precision Medicine w Vivek Subbiah, MD & Nicholas McGranahan as speakers. you are welcome to join us (+ there is a cocktail at the end 🥂🧉🍹🥤🧃🍵☕️ !)
.ESMO - Eur. Oncology is launching a monthly virtual journal club. 3 papers discussed during 1h by the best experts. The goal is to update all colleagues about the latest advances wherever they are in the 🌍. First session on May ! Stay connected ! esmo.org/about-esmo-mee…
Very interesting #ESMOYOC #YO4YO session later today…looking forward to seeing you online !!!
ESMO - Eur. Oncology OncoAlert Maria Kfoury Véronique Debien Joseph Ciccolini Università di Genova Ospedale San Martino Genova francescalongo Evandro de Azambuja, MD, PhD Andres Cervantes
Unequity is the key word from the breast cancer The Lancet commission. A roadmap is proposed. ↘️ these unequities will have measurable impact on BC Survival globally. by charlotte Coles et al. V happy to have participated with Franzoi Maria Alice & Ines Vaz Luis, MD from Gustave Roussy
The #PrecisionOncology webinar presents ESMO’s new proposal for a classification of tissue-agnostic therapeutics. Register now for free and take part in this live interaction with international experts.
And that is a wrap for the Transatlantic conference between Dana-Farber Gustave Roussy around the topic of “liquid biopsies”—thank you to all the faculty, @medscape + Servier
See you next year in Paris !
#
It's today! Are you not in #Boston ❓No worries‼️It is a hybrid event! 👇
events.medscapelive.org/website/68476/
Medscape Dana-Farber Dana-Farber_GU Gustave Roussy Toni Choueiri, MD FabriceAndre
TILs = better outcome in pts with early stage TNBC who did NOT receive chemo (n=1966). A study by S Michiels Gustave Roussy and col.
Rationale for the ETNA trial testing chemo-free tt in pts with ↗️ TILs / eTNBC led by Barbara Pistilli jamanetwork.com/journals/jama/…
.Ines Vaz Luis, MD will receive a Special Award of ASCO for her role as a Mentor. She has developed a unique team of MDs, social scientists, data scientists, pts. This award illustrates the efforts of Gustave Roussy to train a new generation of colleagues.
Merci a tous les soutiens pour mon #SemiParis au profit de Gustave Roussy . Le parcours est genial mais la fin est hyper dure a cause des crampes 😩🥵
Out in ESMO Open our review on precision medicine in #breastcancer :
📍milestones of genomics to predict drug sensitivity
📍new dimensions of cancer biology
📍future directions of precision medicine
Fernanda Mosele FabriceAndre Stefan Michiels Gustave Roussy
doi.org/10.1016/j.esmo…